XOMA Royalty Corp. (XOMA)
28.71
-0.05
(-0.17%)
USD |
NASDAQ |
Mar 20, 16:00
28.91
+0.20
(+0.70%)
After-Hours: 20:00
XOMA Royalty Research and Development Expense (Quarterly) : 0.281M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Mirum Pharmaceuticals, Inc. | 51.03M |
| Recursion Pharmaceuticals, Inc. | 83.34M |
| InspireMD, Inc. | 3.475M |
| Rezolute, Inc. | 14.35M |
| Lifeward Ltd. | 0.843M |